Absci Corporation ABSI

Set alert

Price alert · ABSI

All alert types
9.69 USD -1.44 -12.94%

At close · Nov 2

9.81 +0.12 +1.24%

After hours · Nov 2, 6:24 PM ET

Bid
9.68 × 2
Ask
9.69 × 2
9.68 Day range 11.32
2.24 52-week range 12.55
YTD
+177.65%
1 year
+126.40%
Open
11.29
Prev close
11.13
Mkt cap
1.66B
Vol
3.81M
Avg vol
3.57M
EPS
-0.79
P/E
0.00
Div yield
0.00%
More statistics
Low
9.68
High
11.32
Forward P/E
-13.98
Beta
2.19
Short ratio
8.22
Inst. own
87.32%
Dividend
0.00
Ex-div date
Earnings
Nov 12, 2026
50-d avg
9.51
200-d avg
6.49
1y target
14.82

1m chart

Chart tools
Interval

Built from the cached one-day intraday bars.

Signals (83)
NameTimeAgo
RSI: OversoldNov 2, 3:58 PM5 hours ago
MACD: Sell SignalNov 2, 3:55 PM5 hours ago
SMA: BearishNov 2, 3:51 PM5 hours ago
MACD: Buy SignalNov 2, 3:44 PM5 hours ago
RSI: OversoldNov 2, 3:35 PM5 hours ago
RSI: OversoldNov 2, 3:32 PM5 hours ago
MACD: Sell SignalNov 2, 3:14 PM6 hours ago
SMA: BearishNov 2, 3:13 PM6 hours ago
RSI: OverboughtNov 2, 3:08 PM6 hours ago
SMA: BullishNov 2, 3:03 PM6 hours ago
SMA: BearishNov 2, 3:02 PM6 hours ago
RSI: OverboughtNov 2, 2:59 PM6 hours ago
RSI: OverboughtNov 2, 2:54 PM6 hours ago
SMA: BullishNov 2, 2:52 PM6 hours ago
SMA: BullishNov 2, 2:42 PM6 hours ago
SMA: BearishNov 2, 2:41 PM6 hours ago
SMA: BullishNov 2, 2:40 PM6 hours ago
MACD: Buy SignalNov 2, 2:40 PM6 hours ago
SMA: BullishNov 2, 2:28 PM6 hours ago
MACD: Sell SignalNov 2, 2:20 PM7 hours ago
MACD: Buy SignalNov 2, 2:11 PM7 hours ago
SMA: BullishNov 2, 2:09 PM7 hours ago
RSI: OversoldNov 2, 2:06 PM7 hours ago
MACD: Sell SignalNov 2, 2:05 PM7 hours ago
SMA: BearishNov 2, 1:57 PM7 hours ago
SMA: BearishNov 2, 1:57 PM7 hours ago
SMA: BearishNov 2, 1:53 PM7 hours ago
SMA: BearishNov 2, 1:50 PM7 hours ago
SMA: BullishNov 2, 1:49 PM7 hours ago
MACD: Buy SignalNov 2, 1:48 PM7 hours ago
SMA: BullishNov 2, 1:47 PM7 hours ago
RSI: OversoldNov 2, 1:43 PM7 hours ago
SMA: BearishNov 2, 1:14 PM8 hours ago
MACD: Sell SignalNov 2, 1:14 PM8 hours ago
SMA: BullishNov 2, 12:58 PM8 hours ago
MACD: Buy SignalNov 2, 12:56 PM8 hours ago
SMA: BullishNov 2, 12:55 PM8 hours ago
SMA: BullishNov 2, 12:50 PM8 hours ago
MACD: Sell SignalNov 2, 12:45 PM8 hours ago
RSI: OversoldNov 2, 12:45 PM8 hours ago
SMA: BearishNov 2, 12:42 PM8 hours ago
SMA: BullishNov 2, 12:39 PM8 hours ago
MACD: Buy SignalNov 2, 12:39 PM8 hours ago
RSI: OversoldNov 2, 12:33 PM8 hours ago
MACD: Sell SignalNov 2, 12:30 PM8 hours ago
SMA: BearishNov 2, 12:26 PM8 hours ago
SMA: BullishNov 2, 12:24 PM8 hours ago
SMA: BearishNov 2, 12:14 PM9 hours ago
MACD: Buy SignalNov 2, 12:09 PM9 hours ago
SMA: BearishNov 2, 12:08 PM9 hours ago
SMA: BullishNov 2, 12:07 PM9 hours ago
RSI: OversoldNov 2, 11:46 AM9 hours ago
SMA: BearishNov 2, 11:43 AM9 hours ago
MACD: Sell SignalNov 2, 11:42 AM9 hours ago
SMA: BearishNov 2, 11:37 AM9 hours ago
SMA: BullishNov 2, 11:25 AM9 hours ago
MACD: Buy SignalNov 2, 11:20 AM10 hours ago
RSI: OversoldNov 2, 11:16 AM10 hours ago
MACD: Sell SignalNov 2, 11:14 AM10 hours ago
RSI: OversoldNov 2, 11:14 AM10 hours ago
RSI: OversoldNov 2, 11:10 AM10 hours ago
SMA: BearishNov 2, 11:08 AM10 hours ago
SMA: BullishNov 2, 11:01 AM10 hours ago
MACD: Buy SignalNov 2, 11:01 AM10 hours ago
RSI: OversoldNov 2, 10:49 AM10 hours ago
RSI: OversoldNov 2, 10:43 AM10 hours ago
MACD: Sell SignalNov 2, 10:31 AM10 hours ago
SMA: BearishNov 2, 10:30 AM10 hours ago
SMA: BearishNov 2, 10:30 AM10 hours ago
SMA: BullishNov 2, 10:24 AM10 hours ago
MACD: Buy SignalNov 2, 10:24 AM10 hours ago
SMA: BearishNov 2, 10:23 AM11 hours ago
SMA: BullishNov 2, 10:22 AM11 hours ago
MACD: Sell SignalNov 2, 10:18 AM11 hours ago
SMA: BearishNov 2, 10:17 AM11 hours ago
SMA: BearishNov 2, 10:14 AM11 hours ago
SMA: BullishNov 2, 10:05 AM11 hours ago
SMA: BearishNov 2, 10:04 AM11 hours ago
SMA: BullishNov 2, 10:03 AM11 hours ago
SMA: BearishNov 2, 10:02 AM11 hours ago
SMA: BullishNov 2, 9:58 AM11 hours ago
SMA: BearishNov 2, 9:57 AM11 hours ago
SMA: BullishNov 2, 9:56 AM11 hours ago

Key statistics

Market cap
1.66B
Enterprise value
1.71B
Trailing P/E
0.00
Forward P/E
-13.98
PEG ratio
0.00
Price / sales
1065.30
Price / book
6.75
EPS (TTM)
-0.79
Beta
2.19
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
1.56M
Revenue growth
-46.40%
Free cash flow
-50.59M
Total cash
201.14M
Total debt
3.83M
Return on equity
-57.72%
Shares outstanding
171.61M
Short % of float
26.24%
50-day average
9.51
200-day average
6.49

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 14.82 +52.9% upside
Target (low)
10.00
Target (mean)
14.82
Target (high)
20.00
Ratings (0m) 12 11 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy9
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Nov 12, 2026

Expected Nov 12, 2026. Consensus EPS estimate -0.19763.

Earnings history

Financials — quick view

All financials
ABSI Revenue — quarterly 318.00K
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ABSI Net income — quarterly -33.21M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ABSI EPS — quarterly -0.21
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ABSI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2026Sep 30, 2026-0.19081———
Aug 11, 2026Jun 30, 2026-0.19102-0.18+0.01+5.77%
May 7, 2026Mar 31, 2026-0.20-0.19+0.01+5.00%
Mar 24, 2026Dec 31, 2025-0.16-0.23-0.07-43.75%
Nov 12, 2025Sep 30, 2025-0.19-0.20-0.01-5.26%
Aug 12, 2025Jun 30, 2025-0.19-0.24-0.05-26.32%

Upgrades / downgrades

ABSI analyst upgrades and downgrades
DateFirmActionFromTo
Oct 29, 2026Jefferiesinit—Buy
Oct 16, 2026KeybancmainOverweightOverweight
Oct 12, 2026JP MorganmainOverweightOverweight
Oct 12, 2026HC Wainwright & Co.reitBuyBuy
Sep 23, 2026NeedhamreitBuyBuy
Sep 9, 2026LifeSci Capitalinit—Outperform

About Absci Corporation

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
absci.com

News

Your note

Sign in to keep a note on ABSI — it syncs with the Stock Master app.

Insider holders

ABSI insider holders
InsiderRelationLatest transactionDateShares held
BEDRICK TODDOfficerStock Award(Grant)Mar 1, 2026216,942
BUSCH ANDREASOfficerPurchaseMar 11, 2026421,446
JONASSON ZACHARIAHChief Financial OfficerStock Award(Grant)Mar 1, 2026499,783
MCCLAIN SEANChief Executive OfficerStock Award(Grant)Mar 1, 20268,715,450
MCGINNIS KAREN KDirectorStock Award(Grant)Jun 3, 202648,420
PANGALOS MENELAS NDirectorStock Award(Grant)Jun 3, 2026242,408

Institution ownership

ABSI institution ownership
Holder% heldSharesValueReported
FMR, LLC14.81%25,410,048246.22MJun 29, 2026
ARK Investment Management, LLC7.53%12,925,271125.25MJun 29, 2026
Blackrock Inc.7.09%12,175,302117.98MJun 29, 2026
State Street Corporation4.72%8,097,30878.46MJun 29, 2026
Ameriprise Financial, Inc.4.07%6,991,76367.75MJun 29, 2026
Redmile Group, LLC3.93%6,739,67565.31MJun 29, 2026

Fund ownership

ABSI fund ownership
Holder% heldSharesValueReported
ARK ETF Trust-ARK Genomic Revolution ETF6.17%10,581,097102.53MSep 29, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund4.68%8,022,96777.74MAug 30, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF2.88%4,946,40247.93MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.57%4,407,68542.71MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.27%3,888,88937.68MSep 29, 2026
Columbia Acorn Trust-Columbia Acorn Fund1.68%2,889,06628.00MJun 29, 2026